GCT vs. NBIX
GCT (GigaCloud Technology Inc) and NBIX (Neurocrine Biosciences, Inc.) are both stocks. GCT operates in Software - Infrastructure (Technology), while NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 3 years, GCT returned 69.39%/yr vs 21.73%/yr for NBIX. At a 0.16 correlation, their price movements are largely independent.
Performance
GCT vs. NBIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GCT achieves a -12.40% return, which is significantly lower than NBIX's 24.87% return.
GCT
- 1D
- -1.21%
- 1M
- 2.87%
- 6M
- -17.68%
- YTD
- -12.40%
- 1Y
- 65.75%
- 3Y*
- 69.39%
- 5Y*
- —
- 10Y*
- —
NBIX
- 1D
- -1.91%
- 1M
- 8.85%
- 6M
- 30.43%
- YTD
- 24.87%
- 1Y
- 32.71%
- 3Y*
- 21.73%
- 5Y*
- 12.33%
- 10Y*
- 13.85%
GCT vs. NBIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
GCT GigaCloud Technology Inc | -12.40% | 112.10% | 1.23% | 221.53% | -70.36% |
NBIX Neurocrine Biosciences, Inc. | 24.87% | 3.90% | 3.60% | 10.31% | 13.82% |
Correlation
The correlation between GCT and NBIX is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Aug 18, 2022 | 0.16 |
Fundamentals
GCT:
$1.28B
NBIX:
$17.81B
GCT:
$3.95
NBIX:
$6.50
GCT:
8.71
NBIX:
27.23
GCT:
0.11
NBIX:
0.54
GCT:
0.94
NBIX:
5.87
GCT:
2.48
NBIX:
5.37
GCT:
$1.38B
NBIX:
$3.10B
GCT:
$322.79M
NBIX:
$3.05B
GCT:
$177.88M
NBIX:
$881.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GCT vs. NBIX — Risk / Return Rank
GCT
NBIX
GCT vs. NBIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GigaCloud Technology Inc (GCT) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GCT | NBIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.19 | ||
| Sortino ratioReturn per unit of downside risk | +0.43 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.20 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.59 | 1.50 | +0.09 |
| Martin ratioReturn relative to average drawdown | 3.72 | 3.29 | +0.43 |
Loading charts...
Drawdowns
GCT vs. NBIX - Drawdown Comparison
The maximum GCT drawdown since its inception was -91.11%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for GCT and NBIX.
Loading charts...
Drawdown Indicators
| GCT | NBIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.11% | -97.21% | +6.10% |
Max Drawdown (1Y)Largest decline over 1 year | -39.13% | -20.90% | -18.23% |
Max Drawdown (3Y)Largest decline over 3 years | -73.16% | -42.89% | -30.27% |
Max Drawdown (5Y)Largest decline over 5 years | — | -42.89% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -46.39% | — |
Current DrawdownCurrent decline from peak | -33.57% | -1.91% | -31.66% |
Average DrawdownAverage peak-to-trough decline | -55.65% | -43.74% | -11.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.75% | 9.52% | +7.23% |
Volatility
GCT vs. NBIX - Volatility Comparison
GigaCloud Technology Inc (GCT) has a higher volatility of 12.16% compared to Neurocrine Biosciences, Inc. (NBIX) at 8.08%. This indicates that GCT's price experiences larger fluctuations and is considered to be riskier than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GCT | NBIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.16% | 8.08% | +4.08% |
Volatility (6M)Calculated over the trailing 6-month period | 50.94% | 23.42% | +27.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.57% | 31.73% | +45.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 143.64% | 32.83% | +110.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 143.64% | 39.03% | +104.61% |
Dividends
GCT vs. NBIX - Dividend Comparison
Neither GCT nor NBIX has paid dividends to shareholders.
Financials
GCT vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between GigaCloud Technology Inc and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GCT vs. NBIX - Profitability Comparison
GCT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, GigaCloud Technology Inc reported a gross profit of 85.85M and revenue of 359.49M. Therefore, the gross margin over that period was 23.9%.
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.
GCT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, GigaCloud Technology Inc reported an operating income of 42.48M and revenue of 359.49M, resulting in an operating margin of 11.8%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.
GCT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, GigaCloud Technology Inc reported a net income of 38.12M and revenue of 359.49M, resulting in a net margin of 10.6%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.
Frequently Asked Questions
GCT and NBIX have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GCT has higher volatility (12.16%) compared to NBIX (8.08%). In terms of maximum drawdown, GCT dropped -91.11% vs NBIX's -97.21%.
NBIX currently has the higher Sharpe Ratio (0.99 vs 0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GCT and NBIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer